FR
EN- A-
- A+
-
FDA Approval of IYUZEH™
Théa Announces FDA Approval of IYUZEH™ for the Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-angle Glaucoma or Ocular Hypertension.
more
-
Jean-Frédéric Chibret, president of Laboratoires Théa, won last night in Paris the EY Entrepreneur of the Year 2022 award.
more
-
Jean-Frédéric Chibret, president of Laboratoires Théa, won last night at the hotel de @Ville de Lyon the EY Entrepreneur of the Year 2022 award for the Auvergne Rhône Alpes region.
more
-
Innovation
The leading European ophthalmology pharmaceutical company is the first to offer an innovative hyaluronic acid treatment for the management of dry eye.
more
-
Education
Education and knowledge sharing have always been a tradition for the Chibret family. That's why Théa supports many educational projects and activities.
more
Innovation a pillar of Théa
The Théa research effort is the combination of an ambitious open innovation policy and "in-house" R&D
department that has proven its worth.
Théa Open Magazine Let's Open Our Eyes
Ophthalmology around the world, the fight against trachoma, education, ... "Open" results from our desire to open our doors ever wider. Enter the world of Théa ..
Access to healthcare Fondation Théa
We have always admired the extraordinary force of character of our ancestor, Paul Chibret, a young military doctor and future ophthalmologist, who, in 1870, left his home town in France to relieve human suffering in Algeria, and more specifically fight against the disease trachoma.
140 years ago, Paul Chibret showed us the way. Today it is our duty and our joy to be able to pursue his fight.
Théa careersBuilding and growing together
Théa’s human capital ensures its prosperity and constitutes its main strategic resource.
Visit Théa Careers page
Professions
Théa offers rich and varied professions. Whatever your profile, there is surely something for you at Théa!
plus
Management ethics
We believe that in order to ensure the continuity of the group and remain at the forefront in an ever-changing world propelled...
plus
Growing Together
Our priority is to grow with our workforce by developing skills, recognising potential and involvement, offering regular...
plus
Areas of expertiseWhat is it ?
In the 1950’s, the introduction of the use of preservatives in ophthalmic products to prevent contamination after opening, constituted a considerable advance. Forty years later, numerous publications showed the detrimental effects of preservatives on the cornea, the conjunctiva and the tear film, causing irritation, inflammation and dry eye.
plus
Théa Worldwide
Théa has its own commercial and marketing structure in the main European countries:
France, Italy, Spain, Germany, Poland, Portugal, Belgium, Netherlands, Switzerland, the United Kingdom and Ireland
and in Northern Africa (Morocco) and in South America (Mexico),as well as an exclusive sales force in some countries distributors (Algeria, Tunisia) and distributors throughout the rest of the world.
